Puerarin affects adipose lipolysis and ameliorates obesity by gut microbiota
Frontiers in Microbiology · 03.04.2025 · 16
DOI: 10.3389/fmicb.2025.1567339 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Microbiology, online erschienen am 03.04.2025. Verfasst von Zhaoyi Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Hepatology and Epidemiology, Affiliated Hangzhou Xixi Hospital, Zhejiang Chinese Medical University, Hangzhou, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Obesity has become a widespread metabolic disorder, marked by its escalating global prevalence. Puerarin, extracted from Pueraria lobata , one of the traditional homologies of medicine and food, demonstrates anti-obesity properties. Nonetheless, the mechanisms through which puerarin exerts its anti-obesity effects remain to be elucidated. This study seeks to highlight the potential application of puerarin in obesity management and to investigate the underlying mechanisms involving gut microbiota and lipid metabolism.
Method
Different doses of puerarin were administered to the high-fat diet mice model, and the structure and composition of gut microbiota were analyzed using 16S rRNA sequencing. Q-PCR evaluated the expression of genes related to lipid metabolism.
Result
Our findings demonstrate that puerarin treatment significantly reduces body weight and epithelial and beige fat mass. Furthermore, puerarin alters the structure and composition of gut microbiota, which is associated with metabolism. Additionally, puerarin treatment significantly upregulates gene expression, fatty acid transport protein 5 (FATP5) hormone-sensitive lipase (HSL), adipose triglyceride lipase (ATGL) in epithelial and beige adipose.
Conclusion
Puerarin demonstrates potential in ameliorating obesity by changing the structure and composition of gut microbiota, which enhances the transport of fatty acid and triglycerides hydrolysis within adipose tissue. This study provides a novel perspective on puerarin as a dietary supplement for obesity.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Hepatology and Epidemiology, Affiliated Hangzhou Xixi Hospital, Zhejiang Chinese Medical University, Hangzhou, China.
- Hangzhou Linan District People's Hospital, Hangzhou, China.
- Department of Medical Research Center, Shaoxing People's Hospital, Shaoxing, China.
- Department of Hepatology, Affiliated Hangzhou Xixi Hospital, Zhejiang Chinese Medical University, Hangzhou, China.
Zitieren
APA
Li, Z., Ye, Y., Lai, S., Bao, J., & Fu, A. (2025). Puerarin affects adipose lipolysis and ameliorates obesity by gut microbiota. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1567339
Vancouver
Li Z, Ye Y, Lai S, Bao J, Fu A. Puerarin affects adipose lipolysis and ameliorates obesity by gut microbiota. Frontiers in Microbiology. 2025;16. doi:10.3389/fmicb.2025.1567339
BibTeX
@article{Li2025,
author = {Li, Zhaoyi and Ye, Yingyan and Lai, Shanglei and Bao, Jianfeng and Fu, Ai},
title = {Puerarin affects adipose lipolysis and ameliorates obesity by gut microbiota},
journal = {Frontiers in Microbiology},
year = {2025},
volume = {16},
doi = {10.3389/fmicb.2025.1567339}
}
EUVIMED